Terbutaline is a prescription medication approved by the Food and Drug Administration (FDA) for treating asthma related symptoms. It works by relaxing muscles, which can stop an asthma attack.

Despite the fact that the drug is only approved for treating asthma, many obstetricians have used Terbutaline to try to prevent premature labor or to control contractions during birth. The “off-label” use of the drug has lead to serious disabilities. The serious risks involved in the use of Terbutaline by expectant mothers have been known since 1997.

Researchers have shown that Terbutaline can affect the placenta of a pregnant woman and cause serious birth defects, namely autism. The risks of Terbutaline become even greater in the case of twins.

The risks of Terbutaline during pregnancy are well known. If an obstetrician prescribes Terbutaline to a pregnant woman, they may be liable for the birth defects. Terbutaline attorneys are working on cases in which serious birth defects have resulted from medical negligence.

This entry was posted on Wednesday, May 7th, 2008 at 6:27 am and is filed under Defective Drugs, Medication, Safety, Terbutaline. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.